Zenflow

01/17/2024

We are delighted to announce that three abstracts on the Zenflow Spring System have been accepted to the 2024 American Urological Association meeting! Our data highlights Zenflow's longstanding patient-centered approach, demonstrating durable safety and effectiveness outcomes. We are proud to showcase these achievements at the upcoming 2024 AUA meeting.

05/04/2023

Many thanks to Urology Times for showcasing the recent clinical study results on the Zenflow Spring System presented at .

“Zenflow is a novel minimally invasive surgical therapy that delivers a nitinol device into the prostatic urethra displacing the lateral lobes for improved urinary flow,” explained Dean Elterman, MD.

04/27/2023

The latest clinical results of the Zenflow Spring System will be presented at . Learn more: https://bit.ly/4444gnh

12/22/2022

Check out our latest video on the BREEZE Clinical Study website and get more information about the investigational Spring Treatment for BPH.
breezeclinicalstudy.com

12/19/2022

We are excited to launch our refreshed BREEZE Clinical Study website! Click the link below to learn more about the Zenflow Spring System, an investigational minimally-invasive treatment for BPH (enlarged prostate).
breezeclinicalstudy.com

12/22/2021

Well-deserved! Shreya Mehta, Co-Founder and CTO of Zenflow, Inc., is UCSF Rosenman Institute's Leader of the Month. Learn more about Zenflow's patient-focused therapy and Shreya's leadership advice for healthtech entrepreneurs.

“We really believe our therapy meets an important need for our patients. And that belief is what keeps us going every day."

11/03/2021

Congratulations to Nick Damiano, CEO and Co-Founder of Zenflow, Inc., featured Leader of the Month by UCSF Rosenman Institute. Read Nick's advice for rising entrepreneurs, the power of patient-first design, and what makes Zenflow's Spring System so unique: https://bit.ly/3bxpRuk

His advice for rising healthtech entrepreneurs: Be ready for the long haul; don’t let the extremes get to you; and make sure you have an A-team.

10/20/2021

Kudos to Tom Salemi and MassDevice for highlighting innovation in urology with Zenflow's CEO, Nick Damiano, and President, Susan Stimson. Tune in to hear how Zenflow is advancing treatment of benign prostatic hyperplasia ( ): https://bit.ly/3FYjGxk

The urology specialty faces a critical moment, with 10 urologists ready to retire for every new urologist entering the field. That puts the onus on medical device companies to develop faster, safer and more efficacious ways to break down kidney stones, shrink enlarged prostates and handle other crit...

10/04/2021

Exciting times at Zenflow as the first patient is successfully treated by Dr. Michael Trotter at Pinnacle Surgery Center of Austin, as part of our BREEZE™ pivotal clinical trial. Learn more: https://bit.ly/3k0yR0d

10/04/2021

Big milestone this week! Initiation of our BREEZE™ pivotal clinical trial. “The efficiency of the procedure makes the Zenflow device an exciting new tool in the treatment for .” – Michael Trotter, MD, lead investigator at Midtown Urology Associates. Read the full release: https://bit.ly/3k0yR0d

09/11/2021

Promising clinical results of the Zenflow Spring System highlighted in two sessions at . Patients treated with the Spring System showed statistically significant improvements in their symptoms through 12 months. Read the full release: https://bit.ly/3k0yR0d

06/03/2021

We are thrilled to announce our $24M Series B financing and the appointment of Susan Stimson as President. With the support of accomplished investors including Invus Opportunities, F-Prime Capital, Medical Technology Venture Partners, Golden Seeds, Astia Angels, CloudStone Capital, and SV Tech Ventures, we are one step closer to our mission to provide lasting relief for men suffering from symptoms of an enlarged prostate. Read the full press release: https://bit.ly/3cbJZTJ